V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 10442558 | 10033603 | 1.78 | 80 | Neo-adjuvant (N) | 2019-04-14 | 2019-05-05 | Capecitabine + Oxaliplatin 21day | 02 | null | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 101327131 |
| 10442595 | 10033604 | 1.71 | 84.85 | null | 2021-10-30 | 2021-10-30 | Capecitabine + Oxaliplatin 21day | 02 | null | CAPECITABINE | 100241116 |
| 10442597 | 10033605 | 1.77 | 88.75 | Adjuvant (A) | 2017-07-01 | 2017-07-06 | CAPECITABINE + OXALIPLATIN | 02 | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 100221541 |
| 10442610 | 10033606 | 1.77 | 51.7 | null | 2021-10-06 | 2021-10-31 | CHOP R - 21 days | 02 | null | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 101619748 |
| 10442611 | 10033607 | 1.68 | 70.9 | Palliative (P) | 2018-05-15 | 2018-06-11 | Capecitabine | 02 | N | CAPECITABINE | 100046319 |
| 10442617 | 10033608 | 1.53 | 41.6 | Palliative (P) | 2020-10-14 | 2020-10-14 | Rituximab (Maintenance) | 02 | N | RITUXIMAB | 101282507 |
| 10442625 | 10033609 | 1.67 | 97.3 | Palliative (P) | 2021-02-08 | 2021-02-08 | Rituximab | 02 | N | RITUXIMAB | 100281038 |
| 10442635 | 10033610 | null | 78.8 | Curative (C) | 2016-10-31 | 2016-10-31 | CHOP R - 21 days | 02 | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 100508626 |
| 10442646 | 10033611 | 1.73 | 59.3 | Curative (C) | 2019-06-20 | 2019-06-29 | CAPECITABINE + OXALIPLATIN | N | N | DOCETAXEL | 101192220 |
| 10442651 | 10033612 | 1.72 | 75.2 | null | 2020-04-07 | 2020-04-28 | Capecitabine + Oxaliplatin 21day | 02 | null | CAPECITABINE + OXALIPLATIN | 101604414 |
| 10442658 | 10033613 | 0 | 66 | Curative (C) | 2020-10-13 | 2020-10-23 | CAPECITABINE + OXALIPLATIN | 02 | null | PEMBROLIZUMAB | 101016078 |
| 10442662 | 10033614 | 1.78 | 107 | Palliative (P) | 2016-05-24 | 2016-06-01 | CAPECITABINE + OXALIPLATIN | 02 | N | RITUXIMAB | 100763089 |
| 10442663 | 10033615 | 1.69 | 77.6 | null | 2018-01-01 | 2018-01-23 | PEMBROLIZUMAB | 02 | null | PEMBROLIZUMAB | 101666542 |
| 10442670 | 10033616 | 1.73 | 76 | Curative (C) | 2017-09-10 | 2017-09-10 | CHOP R - 21 days | 02 | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 101220269 |
| 10442679 | 10033617 | 1.78 | 86.6 | Neo-adjuvant (N) | 2017-06-14 | 2017-07-16 | IBRUTINIB | 02 | null | IBRUTINIB | 100342136 |
| 10442686 | 10033618 | 1.78 | 90 | Palliative (P) | 2016-08-15 | 2016-08-22 | PEMBROLIZUMAB | N | N | PEMBROLIZUMAB | 100718138 |
| 10442702 | 10033619 | 1.5 | 67.5 | Neo-adjuvant (N) | 2016-07-11 | 2016-07-11 | PEMBROLIZUMAB | 02 | N | PEMBROLIZUMAB | 101550608 |
| 10442715 | 10033620 | 1.83 | 47.4 | Palliative (P) | 2020-03-07 | 2020-04-05 | IBRUTINIB | N | N | IBRUTINIB | 100230779 |
| 10442723 | 10033621 | 0 | 75.2 | Curative (C) | 2018-04-04 | 2018-04-06 | Rituximab | 02 | N | PEMBROLIZUMAB | 101262939 |
| 10442730 | 10033622 | 1.52 | 93 | Palliative (P) | 2017-04-08 | 2017-05-09 | Capecitabine | 02 | N | CAPECITABINE | 101089721 |
| 10442756 | 10033623 | 1.69 | 81.1 | 03 | 2018-10-18 | 2018-11-05 | Capecitabine + Oxaliplatin 21day | 02 | Y | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 100735942 |
| 10442758 | 10033624 | 1.8 | 46.7 | Curative (C) | 2019-09-26 | 2019-10-23 | CAPECITABINE + OXALIPLATIN | 02 | N | PEMBROLIZUMAB | 100691357 |
| 10442780 | 10033625 | 1.57 | 71.4 | Palliative (P) | 2020-03-31 | 2020-03-31 | IBRUTINIB | N | N | IBRUTINIB | 100507121 |
| 10442795 | 10033626 | 0 | 89.5 | Curative (C) | 2015-06-14 | 2017-12-20 | IBRUTINIB | 02 | N | IBRUTINIB | 101104077 |
| 10442802 | 10033627 | 1.7 | 84.2 | null | 2019-03-06 | 2019-03-22 | Rituximab | 02 | null | RITUXIMAB | 101254467 |
| 10442823 | 10033628 | null | 104.1 | Palliative (P) | 2018-11-27 | 2018-12-06 | Rituximab | 02 | N | RITUXIMAB | 100218418 |
| 10442826 | 10033629 | 1.74 | 77 | 03 | 2016-11-01 | 2016-11-03 | Capecitabine + Oxaliplatin 21day | 02 | N | DOCETAXEL | 100596317 |
| 10442829 | 10033630 | 1.79 | 68.8 | Curative (C) | 2016-02-18 | 2016-02-28 | Capecitabine | 02 | N | CAPECITABINE | 100509223 |
| 10442841 | 10033631 | 1.65 | 58 | Palliative (P) | 2018-11-15 | 2018-11-30 | Docetaxel 75mg/m2 (21 day) | 02 | N | DOCETAXEL | 100111219 |
| 10442847 | 10033632 | 1.6 | 110 | Adjuvant (A) | 2020-05-05 | 2020-05-06 | CHOP R - 21 days | 02 | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 101246664 |
| 10442850 | 10033633 | 1.65 | 89 | 03 | 2019-06-25 | 2019-06-27 | Capecitabine + Oxaliplatin 21day | 02 | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 100825850 |
| 10442854 | 10033634 | 1.75 | 104.1 | null | 2019-03-19 | 2019-03-19 | Capecitabine + Oxaliplatin 21day | 02 | null | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 100498694 |
| 10442862 | 10033635 | 1.75 | 77.7 | 03 | 2018-04-01 | 2018-04-11 | Capecitabine + Oxaliplatin 21day | 02 | N | CAPECITABINE | 101776257 |
| 10442864 | 10033636 | 1.66 | 63.2 | null | 2019-06-21 | 2019-07-11 | CAPECITABINE + OXALIPLATIN | null | null | DOCETAXEL | 100846738 |
| 10442871 | 10033637 | 1.66 | 0 | Adjuvant (A) | 2016-07-05 | 2016-07-27 | CAPECITABINE + OXALIPLATIN | 02 | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 100791530 |
| 10442906 | 10033638 | 1.52 | 74.6 | Disease modification (D) | 2017-07-01 | 2017-07-02 | Capecitabine | 02 | N | CAPECITABINE | 100141257 |
| 10442918 | 10033639 | 1.71 | 89.4 | Palliative (P) | 2020-03-21 | 2020-03-22 | CAPECITABINE + OXALIPLATIN | 02 | N | CAPECITABINE | 101406962 |
| 10442941 | 10033640 | 1.78 | 58 | Curative (C) | 2018-03-01 | 2018-03-12 | Capecitabine + Oxaliplatin 21day | 02 | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 100726655 |
| 10442955 | 10033641 | 1.66 | null | null | 2021-03-29 | 2021-04-15 | CAPECITABINE + OXALIPLATIN | 99 | null | CAPECITABINE | 101235244 |
| 10442975 | 10033642 | 1.84 | 67.8 | Adjuvant (A) | 2018-07-19 | 2018-07-29 | CAPECITABINE + OXALIPLATIN | 02 | N | CAPECITABINE | 101588001 |
| 10442999 | 10033643 | 1.64 | 76.6 | Adjuvant (A) | 2021-09-18 | 2021-09-18 | CAPECITABINE + OXALIPLATIN | 02 | null | DOCETAXEL | 100847644 |
| 10443014 | 10033644 | 1.68 | 66 | Curative (C) | 2019-01-20 | 2019-01-20 | CAPECITABINE + OXALIPLATIN | 99 | N | DOCETAXEL | 101406882 |
| 10443047 | 10033645 | 1.69 | 73.6 | Palliative (P) | 2015-03-02 | 2015-03-19 | CAPECITABINE + RT | N | N | CAPECITABINE | 100631247 |
| 10443075 | 10033646 | 1.78 | 88.3 | null | 2021-07-02 | 2021-07-23 | CHOP R - 21 days | 02 | null | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 100582031 |
| 10443100 | 10033647 | 1.57 | 68 | Adjuvant (A) | 2018-08-11 | 2018-08-11 | IBRUTINIB | 02 | N | IBRUTINIB | 100507237 |
| 10443120 | 10033648 | 1.76 | 76.7 | 03 | 2019-05-14 | 2019-06-10 | Capecitabine + Oxaliplatin 21day | 2 | N | CAPECITABINE | 100256812 |
| 10443126 | 10033649 | 1.76 | 80.3 | Adjuvant (A) | 2018-03-14 | 2018-03-28 | CAPECITABINE + OXALIPLATIN | 2 | N | CAPECITABINE + OXALIPLATIN | 101301800 |
| 10443133 | 10033650 | 1.64 | 61.8 | null | 2022-02-05 | 2022-02-11 | PEMBROLIZUMAB | 02 | null | PEMBROLIZUMAB | 100591174 |
| 10443135 | 10033651 | 1.75 | 63 | null | 2020-07-20 | 2020-07-20 | CAPECITABINE + RT | N | null | CAPECITABINE | 100370073 |
| 10443153 | 10033652 | null | null | Curative (C) | 2019-08-11 | 2019-08-17 | IBRUTINIB | 02 | N | IBRUTINIB | 101865537 |